Resources
- Abatacept (Orencia)
- Adalimumab (Yuflyma)
- Anakinra (Kineret)
- Baricitinib
- Bimekizumab (Bimzelx)
- Blood Monitoring for Biologic Infusions
- Blood Monitoring for Biologic Treatments
- Certolizumab (Cimzia)
- Etanercept (Erelzi)
- FAQs
- Filgotinib (Jyseleca)
- Golimumab (Givobaz)
- Guselkumab (Tremfya)
- Helpline Questions for Flare Up Management
- Hydroxychloroquine
- Infliximab (Remsima)
- Ixekizumab (Taltz)
- Leflunomide
- Oral Methotrexate
- Rituximab (Mabthera Truxima)
- Sarilumab (Kevzara)
- Secukinumab (Cosentyx)
- Subcutaneous Methotrexate
- Sulfasalazine
- Tocilizumab (RoActemra Tyenne Avtozma)
- Tofacitinib (Xeljanz)
- Upadacitinib (Rinvoq)
- Ustekinumab (Wezenla)
- Vaccinations Relating to Rheumatology Medication